Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-03-25
2008-08-19
Davis, Zinna N (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S139000, C546S148000
Reexamination Certificate
active
07414063
ABSTRACT:
The present invention relates to compounds Formula (I): as inhibitors of AKT activity, which are useful for the treatment of susceptible neoplasms and viral infections.
REFERENCES:
patent: 4457757 (1984-07-01), Molteno
patent: 4525589 (1985-06-01), Hidaka et al.
patent: 4678783 (1987-07-01), Hidaka et al.
patent: 5747507 (1998-05-01), Ikegaki et al.
patent: 0 520 336 (1992-06-01), None
patent: 06 100540 (1994-04-01), None
patent: WO 01/64238 (2001-09-01), None
patent: WO 01/91754 (2001-12-01), None
patent: WO 02/50019 (2002-06-01), None
patent: WO 02/083064 (2002-10-01), None
Al-Awar Rima Salim
Barda David Anthony
Dee Albert Gerard
Henry, Jr. Kenneth James
Joseph Sajan
Davis Zinna N
Eli Lilly and Company
Hostettler Danica
McGraw Elizabeth A.
LandOfFree
Inhibitors of Akt (protein kinase B) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of Akt (protein kinase B), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of Akt (protein kinase B) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4000174